Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9465

This table provides the recommended dosage of Daptomycin for injection in pediatric patients aged 1 to 17 years with complicated skin and soft tissue infections (cSSSI), based on their age. The dosage regimen varies from 5 mg/kg to 10 mg/kg, administered once every 24 hours, and infused over either 30 or 60 minutes. The duration of therapy ranges from up to 14 days. It is important to note that the recommended dosage is for pediatric patients with normal renal function, and dosage adjustment for those with renal impairment has not been established.*

This text provides a table outlining the recommended dosage of Daptomycin for injection in pediatric patients aged 1 to 17 years with S. aureus Bacteremia, based on their age groups. It specifies different dosages and durations of therapy based on the age range. The dosages range from 7 mg/kg to 12 mg/kg, administered once every 24 hours with varying infusion durations. The table also notes that the recommended dosage is for pediatric patients with normal renal function and emphasizes that dosage adjustment for pediatric patients with renal impairment has not been established. It is essential information for healthcare professionals treating pediatric patients with S. aureus Bacteremia.*

This document provides the recommended dosage of Daptomycin for injection in adult patients based on their creatinine clearance. It includes specific dosing regimens for Staphylococcus aureus bloodstream infections. For patients with a creatinine clearance greater than or equal to 30 mL/min, the recommended dose is 4 mg/kg once every 24 hours or 6 mg/kg once every 24 hours. For patients with a creatinine clearance less than 30 mL/min, including those undergoing hemodialysis and Continuous Ambulatory Peritoneal Dialysis (CAPD), the recommended dose is 4 mg/kg once every 48 hours or 6 mg/kg once every 48 hours.*

This text provides information about a medication named Daptomycin for Injection, which comes in a vial containing 500 mg. It is indicated for intravenous infusion and is presented as a single-dose vial that should be refrigerated. The reconstitution of the medication should be done with 10 mL of 0.9% Sodium Chloride Injection. The text also mentions the manufacturer, Xelia Pharmaceuticals Inc, and that the product is distributed by Fikma, with the manufacturing taking place in India. Additionally, it provides a code number for identification purposes. Following the instructions included in the package insert is recommended for complete details on dosage and administration.*

This text provides information about a medication called Daptomycin for Intravenous Infusion, specifically about its expiry date, composition, dosage, administration instructions, and storage requirements. It mentions the manufacturer, PremierProRx, the dosage per vial (500 mg), reconstitution instructions, and the necessity to refrigerate the product. It also emphasizes the need to visually inspect the product before use. The distributor's details and contact information are also included.*